跳至主要内容
临床试验/NCT03498820
NCT03498820已完成不适用

Analgesia-Nociception Index Guided Intraoperative Remifentanil Administration Versus Standard Practice : Evaluation of Perioperative Opioid Use

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2018年11月19日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
1
主要终点
Intraoperative remifentanil consumption

研究概览

简要总结

This study compares two groups of patients undergoing a gynecological surgey under general anesthesia: one group in which intraoperative analgesia is guided by the Analgesia-nociception index, and another group in which intraoperative analgesia is managed as in standard practice. The objective is to assess if the Analgesia Nociception Index may result in a decrease in total analgesic drugs consumption, a decrease in post-operative pain and in chronic pain development.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Elective gynecological surgery under general anesthesia
  • Duration of surgery 1-7 hours
  • Duration of hospital stay > 24 hours

排除标准

  • chronic pain
  • chronic analgesic medication
  • neurologic disease
  • psychiatric disease
  • history of addiction
  • kidney or liver failure
  • allergy to any anesthetic or analgesic drug
  • BMI > 35

研究组 & 干预措施

Analgesia Nociception Index

Experimental

Intraoperative remifentanil administration guided by the Analgesia Nociception Index

干预措施: Analgesia Nociception Index (Device)

Usual practice

Active Comparator

Intraoperative remifentanil administration managed in standard practice

干预措施: Remifentanil (Drug)

结局指标

主要结局

Intraoperative remifentanil consumption

时间窗: up to 7 hours after the beginning of general anesthesia

total dose of remifentanil administered to the patient during general anesthesia

次要结局

  • Postoperative morphine consumption(obtained 24 hours after the end of general anesthesia)
  • Persistent pain(Obtained three months after surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验